Study of 84 GCA & Takayasu's pts assessed w/ MRA vs PET scans showing complementary info. 60% agreement betw the two in Dz extent; 68% in Dz activity. MRA better captures disease extent, and PET scan is better suited to assess vascular activity.. https://t.co/RjtxxXAzsa

Its only important if you make an Impact. https://t.co/ySW0hE4XNZ

Lancet article - Baricitinib 4 mg (not 2mg) shown to be effective in SLE. After 24 weeks SLEDAI-2K responses were Bari 4 mg 67% vs 53% PB0. https://t.co/KWqMJcDHF2

Pfizer & Lilly report on Phase 3 Tanezumab (NGF inhibitor) in 698 Knee or Hip OA pts. At 16wks TNZ yielded significantly better pain, function & the Pt Global (vs PBO). Rapidly progressive OA seen in <1.5% on TNZ; 0 on PBO. https://t.co/AubO4PyYJQ